ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 294734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 294734; 2) Community: the network communities that were significantly associated with the response to NSC 294734; 3) Molecule: the relationships between components within communities and NSC 294734; 4) MDR: the compounds that were significantly associated with the NSC 294734.

NSC Compound Enrichment Correlation
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0135714101922724 0.31792002
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0135714101922724 0.45339638
NSC 758670 TANNIC ACID 0.0135714101922724 -0.2606333
NSC 9594 Safranin bluish 0.0135714101922724 0.16925702
NSC 244404 Null 0.0139796580235792 0.23954929
NSC 339137 PHYSALOLACTONE 0.0139796580235794 0.45589487
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0139796580235794 0.19492207
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0139796580235794 0.72102876
NSC 606497 Camptothecin Derivative 0.0139796580235794 0.017944307
NSC 624657 ANTINEOPLASTIC-624657 0.0139796580235794 0.42299213
Total:78  Current:28    [First] [Prev] [Next] [Last]